Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Cells|September 18, 2020
Nano-Enhanced Cancer Immunotherapy: Immunology Encounters NanotechnologyErnesto Bockamp, Sebastian Rosigkeit, Dominik Siegl, et al.Cancer Gene Therapy|October 18, 2020
ERK3/MAPK6 is required for KRAS-mediated NSCLC tumorigenesisKatarzyna Bogucka, Federico Marini, Sebastian Rosigkeit, et al.Macromolecular Bioscience|June 8, 2019
α-Mannosyl-Functionalized Cationic Nanohydrogel Particles for Targeted Gene Knockdown in Immunosuppressive MacrophagesNadine Leber, Leonard Kaps, Aiting Yang, et al.Advanced Healthcare Materials|December 3, 2015
In Vivo Gene-Silencing in Fibrotic Liver by siRNA-Loaded Cationic Nanohydrogel ParticlesLeonard Kaps, Lutz Nuhn, Misbah Aslam, et al.Elife|April 22, 2020
ERK3/MAPK6 controls IL-8 production and chemotaxisKatarzyna Bogucka, Malvika Pompaiah, Federico Marini, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|April 26, 2025
ErbB2/HER2-targeted CAR-NK cells eliminate breast cancer cells in an organoid model that recapitulates tumor progressionJasmin Röder, Tijna Alekseeva, Anne Kiefer, et al.Journal of Cell Science|June 6, 2020
A subset of flavaglines inhibits KRAS nanoclustering and activationHajime Yurugi, Yinyin Zhuang, Farid A Siddiqui, et al.Oncoimmunology|April 11, 2018
Enhanced protection of C57 BL/6 vs Balb/c mice to melanoma liver metastasis is mediated by NK cellsFriedrich Foerster, Sebastian Boegel, Rosario Heck, et al.Nature Communications|April 30, 2020
Proteogenomics analysis unveils a TFG-RET gene fusion and druggable targets in papillary thyroid carcinomasAswini Krishnan, Jean Berthelet, Emilie Renaud, et al.International Journal of Cancer|July 31, 2021
Definitive evidence for Club cells as progenitors for mutant Kras/Trp53-deficient lung cancerSebastian Rosigkeit, Marie Kruchem, Dorothe Thies, et al.Pageof 2